TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 6.195

-2.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: James Reynolds who wrote ()	12/11/1996 2:01:00 PM
From: Boyce Burge	of 557

I own a few shares and I try to follow it. Not a lot of news. Basically bought it because of the breadth of their gene therapy platform, and because I thought it might be a good takeover target at some point. Except for Vical, most gene therapy cos have big partners or owners (eg Chiron and their GT co.,cant remember what its called). TGEN has trials going on at Stanford for Cystic Fibrosis. They were positive in phase 1 and are going into phase 2. TGEN was recommended by an analyst at Wheat First (Wole Fayemi) who used to be at H&Q. He (she?) predicted a share price fd 15 by year end 1997. Of course I dont believe that, but it will be a good thing to have in your portfolio come the year 2000.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext